valu usd unless otherwis note
view lower ep consensu
pt estim compani could face
ep headwind tariffs/fx howev believ
share least partial discount headwind share
sinc trump administr releas first tariff list
under-perform ihi time period
tariff current repres near-term overhang
least partial price share lower top-
end ep guidanc nickel despit beat consensu
ep estim nickel ep guidanc reduct blame
higher reinvest back busi impact
 tariff chines import good went effect juli
howev exposur tariff increas sinc earn
accordingli undertaken deep dive var tariff exposur
 /china trade war could impact var ep
believ var import china estim
var total annual variabl manufactur cog china
assum tariff rate impact
tariff chines import good could neg impact
base case annual separ believ
var import china estim var total
annual cost import good china could
tack tariff impact chines tariff
import good could result annual ep hit base
lower ep estim estim could
face total ep headwind tariff
fx lower ep estim
vs fce seek exclus
neg impact first tariff believ
make reason argument letter ustr
compani receiv exclus howev state
timelin long take ustr review/process exclus
request addit exclus process place
tranch tariff
event astro investor day earn oct
expect investor focu astro center around ramp recent
thought guidanc impact tariff strategi
manag outlook mr-linac recent leadership chang
health radiat oncolog market also expect
discuss vision real-tim adapt therapi term could
get us posit would like see tariff exclus
price prior trade day market close estimate unless otherwis note
believ varian share perform line peer
group follow key reason
lead suit radiat oncolog product
medium-term world-wide radiat oncolog market
growth difficult forecast earn growth
tie manag abil grow top line
supplement modest oper leverag
growth acceler backlog grew
growth distributor convers trend remain difficult
forecast continu us hospit consolid trend
toward hypofraction us reimburs cut
bundl initi could lead medium-term pressur
softwar servic busi appear
healthi imag compon show earli sign
revenu service/licens contribut
revenu expect grow busi
strong high-single-digit y/i go forward addit
expect busi continu drive oper
margin expans softwar gross margin
rang servic gross margin
rang compar overal oncolog
system margin
proton therapi repres growth driver still
uncertainti whether signific invest
therapi produc strong futur
proton-therapi busi begin break even
profit point view
proven clinic benefit proton therapi versu photon/
x-ray-bas linac vault size cost commerci
reimburs difficulti limit adopt
bring size cost proton therapi
system insur make proton reimburs less
favor adopt therapi may remain slow
upcom potenti catalyst event astro investor
day earn oct potenti proton
hospit capit spend
competit risk elekta slower-than-
expect ramp proton therapi radiat oncolog
reimburs risk hospitals/freestand center
on-going lawsuit fda regulatori risk surround new
systems/softwar modul risk tariff risk
bloomberg capit market estim upside/downside/target
base scenario assum share rise
share base weight averag dcf price-to-earnings ev/ebitda
assum world-wide radiat oncolog market
grow y/i varian slightli grow world-wide
oncolog system separ assum
proton therapi show mid-single-digit y/i growth
bottom line assum long-term non-gaap
oper margin leverag non-gaap ep growth
howev ep growth constrain assum
ep headwind tariff fx
upsid scenario assum share rise
share assum world-wide radiat oncolog
market grow high-single-digit y/i varian grow
growth oncolog system separ
assum proton therapi show low-double-digit y/i
growth bottom line model
non-gaap oper margin leverag non-gaap
downsid scenario assum share fall
assum declin reimburs
bundl slow demand linac system put
pressur price also assum elekta regain
system momentum slow recent share gain
accordingli model low-single-digit y/i constant-curr
growth oncolog system separ
assum proton therapi adopt acceler
reimburs fall bottom line model
non-gaap oper margin leverag
note look health var end market undertak market share analysi
major radiat oncolog manufactur conduct deep dive var potenti
exposur /china trade war look var fx exposur comment
recent leadership chang combin insight takeaway recent
held ndr var ceo wilson cfo gari bischop occur follow
compani result key takeaway
world-wide hospit capital-expenditure market growth
tracker track hospit capital-expenditure point y/i constant currenc
growth world-wide hospit capital-expenditure market repres fastest growth
seen sinc world-wide hospit capital-expenditure growth stand y/i constant currenc
pickup y/i growth report y/i growth larg
imag manufactur like philip note seen acceler imag
market growth y/i rang low-single-digit y/i rang sever year ago
attempt explain acceler philip manag said instal
base old drive activ instal base upgrad program addit
believ mani hospit north america busi consolid
capital-expenditure go system philip manag believ
electron health record ehr market slow bit capit avail
area like imag
elekta manag believ radiat
oncolog market growth pick
confer call manag estim trail month radiat
oncolog market growth y/i constant currenc backlog growth
rang estim y/i constant currenc revenu growth world-wide radiat
oncolog market past month uptick y/i trail
month radiat oncolog market growth constant currenc report
confer call seen consist pickup trail month radiat
oncolog market sale growth past six quarter believ radiat oncolog
manufactur benefit overal pickup world-wide hospit capital-expenditure trend
well faster backlog revenu convers time due partli geograph mix order
front elekta manag estim trail month radiat oncolog
market growth y/i constant currenc point recent pickup growth
right in-line y/i estim manag believ strong macroeconom
trend defin benign currenc volatil europ respons recent
pickup market growth topic linac price elekta manag recent said
capit market day price low-single-digit y/i believ
partli due lack innov linac portfolio outsid final believ
world-wide radiat oncolog gross order trend remain strong point
meaning slowdown radiat oncolog market growth
may-juli
januari may-juli
market leader benefit pick-up
radiat oncolog market sale growth long
var oncolog system revenu grown y/i constant currenc trail
month slightli market growth averag cycl time order var
backlog histor month howev recent experienc higher
order mix tender driven matur market like emea result faster cycl
time order specif low percent revenu come
order less month old compar low percent revenu
came order less month old despit var oncolog
system order backlog y/i addit note var gross order
y/i constant currenc past month expect compani return
normal y/i constant currenc revenu growth
var world-wide gross order market share gain slow
past month elekta regain
past month elekta world-wide gross order y/i constant currenc
compar y/i y/i argu elekta
benefit easier y/i comp rel competitor initi order
respons recent world-wide gross order share gain elekta may
true believ elekta regain momentum lose world-wide gross
order market share last year exclud estim elekta gross
order would low-single-digit y/i constant currenc past month
analysi consist elekta manag commentari ct-base linac
busi continu grow y/i howev also indic continu take share
elekta ct-base linac part radiat oncolog market
sale basi past month elekta world-wide sale y/i constant
currenc compar y/i appar elekta regain
sale momentum under-perform market sale growth prior
year recent capit market day elekta manag laid five year goal
target revenu compound-annual-growth-rate y/i current market growth
elekta financi target histor proven aggress howev manag believ
abl gain share system part radiat oncolog market
grow servic busi y/i rang next five year addit
elekta manag said capit market day work refresh
linac portfolio ad capabl versa hd system like infin
synergi also work solut china emerg market address
issu like instal system footprint energi requir eas use sound
like compet var exist halcyon system potenti reduc var current
competit advantag emerg market
note forward gross order estim elekta base consensu estim forward gross order estim base forecast
note forward sale estim elekta base consensu estim forward sale estim base forecast
ww gross order market constant currenc revenu market constant currenc medic suppli devic
manag lack clariti potenti tariff impact
limit investor visibl earn believ
result major headwind share
manag recent lower top end ep guidanc nickel despit beat
consensu ep estim nickel confer call
manag blame ep guidanc reduct higher reinvest back
busi impact tariff chines import good went effect
juli manag told us make greater invest softwar emerg
market well recent mobiu evin acquisit var oper expens
y/i first three quarter vs y/i manag
view invest favor expect return invest
separ regard china tariff previous suggest hospit
capital-expenditure manufactur coverag univers like neg impact
recent chines tariff recal juli trump administr impos
tariff varieti import china includ radiotherapi system manufactur
china certain compon import manufactur
servic activ particip offic trade repres ustr
process consid product-specif exclus tariff success certain
product could provid retroact relief tariff date enact
trump administr also releas two addit list product china
impos tariff first list involv tariff went effect
august second list involv tariff increas
begin file said expect import
impact less latter two propos tariff list tariff list effect juli
exhibit past/futur deadlin tariff chines import product
china initi respond tariff announc two list product
subject new tariff upon import china manag suggest
impact first list took effect juli howev compani impact
second list took effect august recent competitor confer
manag said send lot truebeam good china
subcompon halcyon system import china note manag
updat guidanc assum impact first section tariff list
one effect juli includ impact second chines tariff
list took effect august
addit septemb trump administr announc would go
forward new tariff rise year-end good china
begin septemb note tariff list includ
product categori like medic glove microscop nerv stimul well
componentri hear aid area howev major finish good
product categori coverag univers origin list announc
trump administr chines ministri financ respond follow
new retaliatori tariff good tariff rate
depend categori variou good new chines tariff good
effect septemb chines tariff impact good unchang
amount propos tariff list releas august howev magnitud
chines tariff propos good new tranch less oner previous
propos recal ministri financ previous propos tariff rate
list duti effect list request tariffsdeadlinecom specif subhead request appear submiss list rebutt comment duti effect list request tariffsdeadlinedeadlin file request appear hear summari expect list productsaugust rebutt comment date submiss written duti effect list duti effect list product increas request exclusionstbd medic suppli devic
variou categori good tariff list china includ
categori within imaging/radi oncolog equip could impact
overal advam estim china tariff impact medic
deep dive var potenti exposur /china trade
thu far manag provid much quantit qualit commentari
investor regard exposur /china trade conflict may due partli
var on-going commun ustr potenti tariff exclus product
howev convers investor found lack tariff guidanc
frustrat point tariff top current overhang share accordingli
undertaken deep dive chines trade data understand var
potenti exposur /china trade conflict believ analysi trade
data use guid understand var potenti exposur corpor
suppli chain complex typic transpar outsid invest
commun addit caution trade data messi complex analyz
limit data
analysi point var world-wide trade shipment china
behind
began analysi look percentag var overal trade shipment
variou countri found var trade shipment
china uk switzerland germani
remaind variou countri make direct sens us given
know var manufactur site first know var world-wide
manufactur come export product varian
current manufactur one radiat therapi system halcyon
second qualit perspect note manufactur medic linear
acceler palo alto california beij china two countri
show top list var world-wide trade shipment treatment simul
system acceler subsystem manufactur crawley unit kingdom
accessori product manufactur baden switzerland helsinki finland
toulous franc winnipeg canada manufactur high dose rate brachytherapi
system crawley unit kingdom haan germani brachytherapi treatment
plan product charlottesvil virginia manufactur calypso compon
tumor track motion manag product seattl washington final
manufactur compon sub-system proton therapi product system
troisdorf germani uk switzerland germani show countri
var world-wide trade shipment believ make sens given know
compani manufactur network
analysi point var import china china
repres var import import sourc
base analysi trade data believ var import
china uk japan switzerland germani
remaind variou countri import data show
modul sub assembl part good frequent import china
match chines export data show modul ht code
one two frequent export good var chines subsidiari recal
function modul provid high voltag puls microwav transmitt
klystron modul cabinet typic locat insid treatment room contain
distribut system contain emerg shut button linac primari power
analysi point var chines manufactur shipment go
regard china look shipment sever var major chines subsidiari
includ china co ltd trade beij
co ltd trade data show var chines shipment
switzerland remaind variou countri make sens
major var linac system manufactur believ chines
subsidiari suppli subcompon system trade data prove
mani small categori good ship var chines subsidiari
note top categori good export varian medic system china co
ltd base number shipment volum shipment involv follow ht
code transmiss apparatu var china shipment number shipment
volum shipment machin recept convers
transmiss regener voic imag data includ switch rout
apparatu var china shipment number shipment volum
shipment believ mainli repres modul
manufactur china ship separ believ mainli
repres door cover modul manufactur china ship
 term tariff impact product note place
tariff good within ht code first tariff tranch addit place
tariff good within ht code third tariff tranch increas
januari
exhibit chines subsidiari shipment variou countri total
gener administr custom china capit market
exhibit top chines subsidiari shipment ht code base number shipment past
gener administr custom china capit market
exhibit top chines subsidiari shipment ht code base volum shipment past
gener administr custom china capit market
ht codedescriptionbi shipmentsbi volum apparatu radio-broadcast televis whether incorpor recept apparatu sound record reproduc apparatu televis camera digit camera video camera telephon set includ telephon cellular network wireless network apparatu transmiss recept voic imag data includ apparatu commun wire wireless network local wide area network transmiss recept apparatu head part recept convers transmiss regener voic imag data includ switch rout base use x-ray alpha beta gamma radiat whether medic surgic dental veterinari use includ radiographi radiotherapi apparatu x-ray tube x-ray gener high tension gener control panel desk screen examin treatment tabl chair like part accessori includ part articl iron transform static convert exampl rectifi inductor part chines shipment ht codedescriptionbi volum teu apparatu radio-broadcast televis whether incorpor recept apparatu sound record reproduc apparatu televis camera digit camera video camera telephon set includ telephon cellular network wireless network apparatu transmiss recept voic imag data includ apparatu commun wire wireless network local wide area network transmiss recept apparatu head part recept convers transmiss regener voic imag data includ switch rout suitabl use sole princip apparatu head exclud prefabr build head part structur exampl bridg bridg section lock gate tower lattic mast roof roof framework door window frame threshold door shutter balustrad pillar column iron steel plate rod angl shape section tube like prepar use structur iron window frame threshold accessori motor vehicl head chines shipment medic suppli devic
origin ask ustr remov tariff sever ht code
letter ustr ask ustr remov follow ht product categori
section tariff list argu
inclus product categori would caus disproportion harm varian
high-technolog manufactur job advanc technolog
innov potenti life-sav medic system access high-qual cancer care
estim provid high-tech manufactur job
time includ categori would pervers provid competit advantag varian
primari competitor foreign compani manufactur refer elekta
instanc
suggest ht code involv system/rel part halcyon total
import compani china code
total export china code compani
valu import china code
ht code involv import part print circuit board
assembl tungsten shield shield radiat field open protect patient
excess extran radiat multi-leaf collim mlc
incorpor tungsten shield integr radiat therapi system mlc
allow radiat beam conform shape target tumor final ht code
cover part static convert distribut maintain electr
analysi suggest yet move good chines
manufactur import foreign manufactur
establish china import import countri
want analyz whether made chang suppli chain result
 /china trade war chang analysi suggest
mix china vs foreign countri import chang meaning
past coupl quarter overal could find evid trade data
meaning shift product var modul know
manufactur china foreign manufactur facil own compani
preliminarili estim impact tariff
chines import good could neg impact
annual basi
product facil north america europ china howev vast
major var linac manufactur palo alto compani
manufactur capabl linac beij china note compani center
beij encompass oncolog equip manufactur oper educ center
radiotherapi clinic profession custom servic center compani facil
beij squar feet part use manufactur part offic space
open juli believ employe work beij
confirm manag suppli chain var halcyon system global
core element machin manufactur china halcyon system
larg manufactur assembl china also believ older system like
uniqu clinac been/may still manufactur china well halcyon
manufactur move separ facil believ may take time new regulatori
manufactur approv would requir taken order halcyon sinc
system launch may worth note halcyon system still
receiv regulatori approv china manag expect occur end
manag quantifi exact impact current/propos tariff
compani said work suppli chain mitig impact
look potenti tariff impact sever way first base trade data
research estim china repres var total manufactur network
estim suppli linac global annual basi
averag sell price asp assum averag system gross margin
base factor believ var total annual variabl manufactur
system cog china could rang saniti check estim
actual trade data point shipment made
china believ rang right ballpark
tariff entir amount view worst case scenario could equat much
annual hit var gross margin midpoint much
base case var annual ep
exhibit potenti impact tariff chines good import
total estim potenti hit var ep tariff chines
import good attempt break look halcyon specif
note compani book halcyon order vs
develop market analysi
assum quarterli run rate halcyon system ship averag sale
price gross margin tack tariff
assumpt preliminarili estim annual hit gross margin
midpoint tariff halcyon ep front preliminarili estim
could result annual ep hit base case
bullbasebear linac suppli annual world-wide averag world-wide system sale price annual world-wide system revenu averag world-wide system gross averag world-wide system cog percentag world-wide system cog total system cog averag tariff rate chines good import potenti hit tariff chines import share count potenti hit ep tariff chines import impact tariff chines good import exhibit potenti impact tariff chines halcyon system import
addit manufactur subcompon china import
 exampl beij plant produc modul everi system sell
point still potenti compani primari manufactur
facil older uniqu linac recal uniqu var mv only-system sell
around world high prioriti emerg market given subcompon
manufactur believ latter impact harder estim howev preliminari
estim could result potenti annual ep hit repres
differ total estim hit var ep tariff chines import
good estim hit var ep tariff chines import halcyon
estim var import china
regard china look import var major chines subsidiari includ varian
medic system china co ltd varian medic system trade beij co ltd
trade data show var import china
switzerland uk remaind variou countri
make sens major var linac system manufactur
note top categori good import varian medic system china co ltd
 involv follow ht code part accessori relat
apparatu base use x-ray alpha beta gamma radiat whether
medic surgic dental veterinari use includ radiographi radiotherapi
apparatu x-ray tube x-ray gener high tension gener control panel
desk screen examin treatment tabl chair like part accessori
thereof var import china base number shipment
var import china base valu shipment term tariff impact
product note china place tariff good within ht code
announc second tranch tariff went effect august
bullbasebear halcyon linac suppli annual averag halcyon system sale price annual halcyon system revenu halcyon system gross total halcyon system cog averag tariff rate chines good import potenti hit tariff chines import halcyon share count potenti hit ep tariff chines import halcyon impact tariff halcyon system import medic suppli devic
gener administr custom china capit market
exhibit top chines subsidiari import ht code base number shipment
gener administr custom china capit market
ht codedescriptionbi shipment base use x-ray alpha beta gamma radiat whether medic surgic dental veterinari use includ radiographi radiotherapi apparatu x-ray tube x-ray gener high tension gener control panel desk screen examin treatment tabl chair like part accessori includ part articl plastic articl materi head includ enamel anod wire cabl includ coaxial cabl insul electr conductor whether fit connector optic fiber cabl made individu sheath fiber whether assembl electr conductor fit articl iron articl import china exhibit top chines subsidiari import ht code base valu shipment
gener administr custom china capit market
preliminarili estim impact chines
tariff import good could neg impact
annual basi
chines side august tariff impact radiotherapi apparatu lump
two x-ray tax code number includ chines ministri
section tariff list note impact tariff
includ manag guidanc estim china repres
revenu compani total sale china top market also
worth note export sever compon halcyon
china exampl export china beam centerlin
sophist compon halcyon system incorpor var impact
intellectu properti beam centerlin manufactur input export
china integr finish halcyon system china
analysi assum gross margin system sold china base
factor believ var total annual cost import systems-rel good china
could rang saniti check estim actual trade data
point shipment made china note
data may underestim true valu import china believ
rang right ballpark tack tariff
assumpt preliminarili estim averag annual hit gross margin
midpoint tariff import china ep front
preliminarili estim could result annual ep hit base case
ht codedescript valuebi base use x-ray alpha beta gamma radiat whether medic surgic dental veterinari use includ radiographi radiotherapi apparatu x-ray tube x-ray gener high tension gener control panel desk screen examin treatment tabl chair like part accessori includ part shaft includ camshaft crankshaft crank bear hous hous bear plain shaft bear gear gear ball roller screw gear box speed changer includ torqu convert flywheel pulley includ pulley block clutch shaft coupl includ univers joint part gear tooth wheel chain sprocket transmiss element enter separ ball roller screw gear box speed changer includ torqu transform static convert exampl rectifi inductor part power handl capac exceed kva exceed capacitor fix variabl adjust pre-set part dielectr transform static convert exampl rectifi inductor part import china exhibit potenti impact tariff good import china
worth note china match tit-for-tat continu increas tariff
 import far good china worth good china
 worth good china unlik match dollar
dollar basi tariff howev trump administr continu implement
tariff chines govern could choos increas tariff rate
import good addit retaliatori measur like delay device/system
approv more/tough investig safeti inspect led wide
tariff rate rang
total estim impact /china trade war
could impact var gross margin much
ep base case scenario expect
pass cost custom
believ past cost recent /china tariff custom
first relationship import radiat oncolog market particularli alreadi
lead market share world-wide share second right sell on-going
softwar servic exist instal base import softwar servic
typic repres averag linac sell price high margin recur
revenu third survey work channel check suggest elekta alreadi
price competit player market elekta tri break account
believ would benefici cede rel price advantag
elekta elekta manag recent said believ chines tariff give
competit advantag howev china yet seen impact
request propos rpf win rate gone first coupl quarter
vs previous owe win high-end side chines radiat
bullbasebear linac suppli annual china averag system sale price annual system revenu china averag system gross margin total system cog sent averag tariff rate good import potenti hit chines tariff import share count potenti hit ep chines tariff import impact tariff good import china exhibit potenti impact /china trade war tariff
quick overview tariff exclus process
juli trade repres ustr announc process appli
exclus product newli impos addit duti certain item import
china process stakehold may request particular product
broader specif part number classifi within cover tariff classif
exclud addit duti exclus request may file interest
person includ trade associ exclus request must receiv octob
first tariff list list decemb second tariff list list
exclus grant ustr effect retroact effect date
addit duti extend one year public exclus
determin request exclus must includ follow
identif particular product term physic characterist
dimens materi composit characterist distinguish
five product within cover eight-digit subhead
subhead htsu applic particular product
request exclus
annual quantiti valu chinese-origin product requestor
purchas last three year
whether particular product avail china address factor
requestor address specif whether particular product and/or
compar product avail sourc unit state and/or third
whether imposit addit duti particular product would caus
sever econom harm requestor interest
whether particular product strateg import relat made china
chines industri program
weigh potenti posit neg could
argu exclus decis ustr
make argument tungsten mainli produc china
would difficult sourc countri
base exclus inform request ustr may difficult show
good sourc china avail china sourc
countri although may take time sourc elsewher
howev may case difficult sourc tungsten countri outsid
china argu origin letter ustr limit sourc
tungsten especi domest commerci product
potenti impact /china trade war tariffsbullbasebearpotenti hit ep tariff chines import potenti hit ep chines tariff import total potenti impact /china trade war medic suppli devic
primari tungsten last count held world tungsten reserv accord
estim tungsten product global tungsten reserv
china varian believ would face enorm challeng secur tungsten
shield non-chines sourc say resort altern tungsten
shield would less cost-effect would undermin compani goal provid
lighter versatil radiat therapi system
argu could take well year bring new supplier say
potenti suppli disrupt would impact manufactur well
 servic busi
also argu origin letter ustr sourc equal high-qual
compon outsid china price would allow cost competit maxim
patient access newest technolog addit argu even
could chang supplier make compani less reliant china would result
massiv disrupt oper process bring new supplier potenti
take well year new supplier would requir var continu
manufactur new system replac upgrad compon need
already-instal system result could propos tariff disrupt var
manufactur also could imped var servic busi
var busi chang compon supplier var system would subject
rigor screen process signific transit work qualif process base
fda regul moreov would need work new supplier coordin up-
front engin qualiti control given replac upgrad order would
piecem unlik would high volum order one part potenti
make unit cost secur new supplier prohibit
propos exempt subcategori within ht code radiat
oncolog addit compani argu product life-sav
natur high-technolog job put risk tariff
includ posit benefit potenti receiv exempt
first tariff updat model base analysi section
case steel aluminum case much exclus request compani appear
grant expect argu linac unfairli lump
gener code diagnost x-ray base equip tariff impos
exampl origin letter ustr suggest ustr exempt
subcategori ht product categori encompass system part includ part
static convert either exclus medic use even narrow exclus
oncology-focus radiat therapi use separ argu origin letter
ustr product deliveri therapi diagnost natur provid life-sav
treatment option cancer patient believ analysi prevent ustr
impos tariff pharmaceut includ life-sav cancer drug appli
equal life-sav radiotherapi cancer treatment final compani argu
tariff would jeopard opportun manufactur high-technolog radiat therapi
system compon place high-technolog manufactur job
broadli med-tech lobbi group larg success thu far
protect industri tariff
overal note med-tech lobbi group thu far arguabl pretti effect
limit impact tariff med-tech industri specif ustr remov
med-tech product propos section list went effect juli
howev med-tech product impact juli tariff
tariff list addit worth med-tech relat product compon part
accessori raw materi includ second tariff ustr tariff list
advam argu enjoy trade surplu china medic devic
diagnost ustr list neglig med-tech trade
deficit china continu shrink radiat oncolog
specif argument made bilater trade surplu
 enjoy radiotherapi system
state timelin ustr review process exclus
request howev analysi suggest much exclus
request grant section case
ustr evalu request individu take account whether exclus
would undermin object section investig howev state
timelin long take ustr review process exclus request
exampl section case baker mckenzi second largest intern law firm
world estim exclus petit file
act first month includ exempt denial
success rate commerc secretari wilbur ross blame slow roll-out exempt
approv process lack fund depart accord bloomberg
septemb exclus petit file fewer
case decid base analysi public document associ
section case abl find case exclus either
grant deni approxim case receiv exclus grant
design remaind deni
note two import ht code chines product import
 includ place tariff good within ht code
first tariff tranch understand seek
exempt good ht code addit place tariff
good within ht code increas januari
third tariff tranch understand stand current abl
seek exempt good ht code
exhibit percentag exclus petit act classifi
either grant deni
conserv assum receiv exclus
ustr updat model believ compani put reason
argument good exclud tariff
laid view reason argument good import
china exclud tariff estim tariff impact meaning
var ep potenti hit ep unclear whether
enough show ustr tariff result sever econom harm compani
one question ask ustr questionnair addit chines
govern shown prefer toward medic institut choos domest
produc large-scal medic equip believ exact situat trump
administr tri discourag tariff said var competitor
said believ linac specif contempl china
manufactur china industri develop plan
overal spirit conserv assum model abl
garner tariff exclus product said certainli worth point
chines radiat oncolog firm wont bear much cost tariff
chines import good export much radiotherapi system
 anyth tariff would give var main competitor elekta base sweden
competit advantag note elekta manufactur presenc
elekta main manufactur hub crawley uk beij china
offici exempt process first tranch
tariff addit tranch tariff
seek exclus neg impact first tariff
research uncov file exclus request regard first tranch tariff
august believ file sooner versu later believ compani want
begin discuss product exclud tariff
want last compani submit exempt worth note
exclus process place tranch tariff trump administr
justifi decis say give compani three month
transit suppli chain away china rais tariff januari
tranch good
ramp linac product new brazilian
manufactur plant wont impact near-term
headwind /china trade war
worth note alreadi made invest brazil work build
linac manufactur capabl region help bring cost per linac
time manufactur ramp howev facil meaning chang
near-term headwind /china trade war provid histori var
situat brazil recal brazilian minist sign deal
build latin america first radiotherapi equip manufactur plant locat
jundia paulo state total expect invest cover acceler
purchas expans project make servic avail new region
brazilian facil open novemb manufactur wareh
oper facil becom oper minimum compon
accessori equip softwar must made brazil per agreement varian
also respons train healthcar profession brazil current
train la vega estim clinician therapist brazil
train first year addit agreement brazil govern buy
linear acceler compani cost per system brl
time agreement
fx also weigh var result currenc turn
tailwind headwind
dollar spot index sinc compani report result juli
note euro sinc var earn sterl sinc var
earn yen sinc earn import currenc
accordingli see meaning increment hit var result fx versu
previous expect unfortun var currenc tailwind guidanc
turn currenc headwind estim currenc neg
impact top-line hedg currenc exposur
largest hedg surprisingli euro yen british pound howev believ
could still much ep headwind var currenc
exhibit impact fx var y/i top-line growth
adjust model post ndr var result
deep dive analysi believ street ep estim
aggress given potenti tariff fx headwind
rais revenu estim vs fce
y/i constant currenc y/i report manag guidanc y/i report
ep estim move lower vs fce y/i
ep beat off-set increas oper expens spend
impact recent enact tariff compar manag ep guidanc
also increas revenu estim
vs fce y/i constant currenc howev ep estim move
lower street low vs fce y/i account
increas oper expens spend well impact recent enact tariff
recent fx fluctuat acknowledg investor visibl ep low given
lack guidanc manag potenti tariff impact howev
comfort well street ep given analysi var ep
would get us posit share
term could get us posit share tariff exclus ustr
evid sustain high-single-digit y/i radiat oncolog market growth and/or
meaning would repres potenti catalyst us warm share one
point worth make market close yesterday announc appoint
kolleen kennedi formerli presid oncolog system new role presid proton
solut chief growth offic ms kennedi well known street
presid oncolog system past year new role ms kennedi
respons grow var proton solut offer well overse compani
acquisit integr offic strateg program manag organ custom
experi initi separ chri toth formerli presid global commerci field
oper succeed ms kennedi new presid oncolog system
execut report directli wilson var presid ceo overal ms kennedi
appoint new role signal us may full pipelin deal
compani could execut believ appetit deal evidenc
recent fail sirtex medic bid previous said believ
could interest potenti area like softwar intervent oncolog mr-
linac long-term even radiopharmaceut cancer diagnost
import event attend astro
expect investor focu astro meet san antonio texa octob
center mainli around futur adapt radiotherapi outlook mr-linac
particularli given june ce mark august file elekta uniti
provid brief preview astro would point sever import
investor event take place astro includ elekta investor meet preliminari
date/tim octob morn investor meet octob cdt
iba investor meet octob cdt investor meet octob
cdt worth note expect host formal investor event
year astro meet host meet analysts/investor
eventdatetimelocationviewray investor meetingoctob cdtomni la mansin del rio colleg st san antonio tx iberian roomselekta investor meetingoctob like tbaiba investor meetingoctob cdtgrand hyatt san antonio east market street san antonio tx presidio room floorvarian investor meetingoctob cdtgrand hyatt san antonio east market street san antonio tx texa ballroom adatetimelocationeventoctob cdttheater exhibit hallbreast cancer challeng today solut tomorrow sponsor symposium octob cdttheater exhibit hallmri-guid radiotherapi imag tumor respons therapi sponsor symposium octob cdtmarriott riverwalk alamo ballroom cadvanc sbrt manag prostat cancer sponsor symposium octob cdttheater exhibit halldynam track motion correct year accuray leadership sponsor symposium octob cdttheater exhibit hallmri-guid radiotherapi clinic outcom summari prospect trial medic suppli devic
recent /eu radiat oncologist survey result convers
radiat oncologist recent astro meet suggest increas
interest mr-linac
expect main focu astro center around outlook mr-linac whether
system nich market larg academ center could broadli
adopt recal third annual radiat oncolog survey publish april
radiat oncologist believ mr-linac like mridian linac elekta
system differenti rel standard ct-base linac approxim
radiat oncologist vs prior year survey expect practice/hospit
purchas mr-linac current price point interestingli similar percentag
radiat oncologist hospit freestand center expect practice/hospit
purchas mr-linac current price point suggest demand
system outsid larg academ set howev premium price point still
barrier adopt center anoth radiat oncologist
hospital-bas radiat oncologist freestand center-bas radiat
oncologist say practice/hospit would purchas mr-linac cost system
came around cost standard ct-base linac
overal radiat oncologist estim mr-guid linac captur market share
practice/hospit one year two year five year
interestingli radiat oncologist hospit expect mr-linac captur
market share five year time practic vs radiat oncologist
freestand center current mr-linac program develop
radiat oncologist suggest acquir gain presenc
part market still decid mr-linac space believ
elekta collabor philip move forward lay earli groundwork
real-tim optim capabl mr-linac well next-gener mri-pet
combin system radiotherapi still year away commerci
thought head astro investor meet
specif host investor meet octob cdt
astro expect focu center around ramp new product introduct halcyon
hyperarc oncolog veloc eclips etc product pipelin updat
oncolog system proton therapi preliminari thought guidanc impact
tariff full year result strategi post fail sirtex medic bid manag
thought outlook mr-linac address competit challeng
elekta mridian system health radiat oncolog market
expect manag go major updat regard long-term
year target laid compani mid-year review may
expect discuss vision adapt therapi compani
plan combat competit mr-linac elekta/vray medium-term
futur pipelin front expect also discuss vision adapt therapi
compani previous said think mr-linac way deliv real-
time adapt radiotherapi exampl current sponsor clinic trial
electromagnetic-guid real time adapt radiotherapi use mlc track lung
var calypso technolog use beacon around cancer lesion
question electromagnet transpond send real-tim local mlc
track system updat mlc pattern send new leaf posit
mlc control treatment linac
howev believ may develop even eleg solut deliv real-
time adapt radiotherapi involv abil monitor tumor motion without
implant marker recal last year astro meet said plan bring
adapt therapi halcyon system near futur follow addit
adapt therapi featur truebeam shortli thereaft manag given specif
timefram initi said goal adapt therapi solut
abl deliv adapt plan meaning way normal minut
treatment slot said attempt use multimod imag
fuse imag differ modal togeth
patent work suggest may look idea iter
imag reconstruct approach drive futur real-tim adapt therapi
heard public address detail expect overcom
major challeng kilovoltag kv imag base method includ rare abl
continu track tumor due inferior tumor visibl kv imag
overlap anatom structur estim tumor posit base
imag inform howev believ way overcom
cbct scan day treatment potenti fuse pre-
treatment imag variou treatment modal use compani veloc softwar
use rapidplan optim plan could use intermitt kv imag
updat model paramet well potenti even continu extern
respiratori signal like var real-tim posit manag system imag frame
tumor posit could predict respiratory-correl model tumor
posit kv imag could measur templat match final predict
measur could combin base distribut recent
estim uncertainti templat match
exact technolog use accomplish yet announc fda
approv knowledg howev gener believ would want accomplish
reconstruct project imag cbct scan gener simul project
data compar simul project data project imag cbct scan
determin residu volum base comparison use residu volum
determin accur reconstruct volum could use reconstruct volum
segment tumor potenti one organ align tumor plan
volum ct scan identifi chang shape tumor proxim
tumor organ chang use alter radiat treatment plan
even fine-tun patient posit via compani perfectpitch couch
alreadi use hyperarc technolog
stand-alone price target perform discount cash flow dcf price-to-earnings
ev/ebitda analysi come intrins valu varian share get price
target assign weight intrins valu calcul dcf
analysi weight intrins valu calcul price-to-earnings analysi
weight intrins valu calcul ev/ebitda
analysi assumpt use analysi includ follow dcf analysi
use wacc assum termin valu ev/ebitda multipl separ
assign target forward price-to-earnings multipl varian slightli varian large-cap
peer group averag target forward ev/ebitda multipl slightli
varian large-cap peer group averag believ slight premium group averag
multipl warrant given expect superior medium-term growth rel
group price target support sector perform rate
risk rate price target
risk price target rate includ slow hospit capit spend
competit risk elekta var two main oncolog system competitor
slower-than-expect ramp proton therapi market radiat oncolog
reimburs risk hospit freestand center on-going lawsuit fda
regulatori risk surround new systems/softwar modul risk tariff risk
varian headquart palo alto ca world lead manufactur medic
devic treat cancer medic condit radiotherapi radiosurgeri
proton therapi brachytherapi radiotherapi use treat head neck prostat
lung liver breast pancreat gynecolog cancer varian two main report
segment oncolog system total revenu proton therapy/oth
total revenu januari spin-off imag compon busi
complet began regular way trade nasdaq global select
revenu
